Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D321-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 |
filingDate |
2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd513603fc1f9ac2316ec8b05decf1b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_117631430950a2360d8479befbc6f35d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7e706a6cf7452432c2c6ab9a65e8ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cac38668bec1ffda1289ed3be75278a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689e653dcd987b8c9d752242dab62837 |
publicationDate |
2008-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-200812573-A |
titleOfInvention |
Co-therapy for the treatment of epilepsy and related disorders |
abstract |
The present invention is directed to co-therapy for the treatment of epilepsy and related disorders comprising administering to a subject in need thereof, co-therapy with a therapeutically effective amount of a benzo-fused heterocycle sulfamide derivative and a therapeutically effective amount of one or more anticonvulsant and/or anti-epileptic agents. |
priorityDate |
2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |